© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
CERo Therapeutics Holdings, Inc. (CERO) stock declined over -1.28%, trading at $2.31 on NASDAQ, down from the previous close of $2.34. The stock opened at $2.45, fluctuating between $2.30 and $2.58 in the recent session.
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Employees | 8 |
Beta | -0.46 |
Sales or Revenue | N/A |
5Y Sales Change% | 0% |
Fiscal Year Ends | N/A |
Sector | Healthcare |
Industry | Biotechnology |
CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) stock price is $2.31 in the last trading session. During the trading session, CERO stock reached the peak price of $2.58 while $2.30 was the lowest point it dropped to. The percentage change in CERO stock occurred in the recent session was -1.28% while the dollar amount for the price change in CERO stock was -$0.03.
The NASDAQ listed CERO is part of Biotechnology industry that operates in the broader Healthcare sector. CERo Therapeutics Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
CERO's closing price is 4.53% higher than its 52-week low of $2.21 where as its distance from 52-week high of $1,280.00 is -99.82%.
Number of CERO employees currently stands at 8.
Official Website of CERO is: https://www.cero.bio
CERO could be contacted at phone 650 407 2376 and can also be accessed through its website. CERO operates from 201 Haskins Way, South San Francisco, CA 94080, United States.
CERO stock volume for the day was 147.79K shares. The average number of CERO shares traded daily for last 3 months was 999.33K.
The market value of CERO currently stands at $6.01M with its latest stock price at $2.31 and 2.6M of its shares outstanding.